NCT04807335View on ClinicalTrials.gov

Study of CT001 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

March 17, 2021

Primary Completion Date

June 2, 2021

Study Completion Date

June 2, 2021

Conditions
Bioavailability
Interventions
DRUG

CT001

nasal spray

DRUG

Ketamine

iv single dose

DRUG

sufentanil

iv single dose

Trial Locations (1)

2400

Dantrials, Copenhagen

Sponsors

Lead Sponsor

Cessatech A/S
All Listed Sponsors
collaborator

Dantrials Aps

INDUSTRY

collaborator

Smerud Medical Research International AS

OTHER

lead

Cessatech A/S

INDUSTRY

NCT04807335 - Study of CT001 in Healthy Volunteers | Biotech Hunter | Biotech Hunter